Early prediction of changes in weight during six weeks of treatment with antidepressants

Journal of Psychiatric Research

Volumn 38, Issue 5, 2004, Pages 485-489

  Himmerich, Hubertus ^a   Schuld, Andreas ^a   Haack, Monika ^a   Kaufmann, Christian ^a   Pollmächer, Thomas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Antidepressants; Leptin; Prediction; TNF; Weight gain

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; DIAZEPAM; HALOPERIDOL; LEPTIN; LITHIUM; LORAZEPAM; MIANSERIN; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PSYCHOTROPIC AGENT; TIANEPTINE; TRANYLCYPROMINE; TRIMIPRAMINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VENLAFAXINE;

ADULT; ARTICLE; BIOASSAY; BODY WEIGHT; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; PREDICTION; PRIORITY JOURNAL; SIDE EFFECT; WEIGHT GAIN;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; FORECASTING; HUMANS; LEPTIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 4544226457     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2004.02.002     Document Type: Article

References (24)

1. Allison D.B., Casey D.E. Antipsychotic-induced weight gain: a review of the literature. J. Clin. Psychiatr. 62(Suppl 7):2001;22-31
2. Baptista T., Teneud L., Contreras Q., Alastre T., Burguera J.L., de Burguera M., de Baptista E., Weiss S., Hernandez L. Lithium and body weight gain. Pharmacopsychiatry. 28:1995;35-44
3. Blin O., Micallef J. Antipsychotic-associated weight gain and clinical outcome parameters. J. Clin. Psychiatr. 62(Suppl 7):2001;11-21
4. Brömel T., Blum W.F., Ziegler A., Schulz E., Bender M., Fleischhaker C., Remschmidt H., Krieg J.C., Hebebrand J. Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol. Psychiatr. 3:1998;76-80
5. Fava M., Judge R., Hoog S.L., Nilsson M.E., Koke S.C. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. J. Clin. Psychiatr. 61:2000;863-867
6. Fernstrom M.H., Kupfer D.J. Antidepressant-induced weight gain: a comparison study of four medications. Psychiatr. Res. 26:1988;265-271
7. Garland E.J., Remick R.A., Zis A.P. Weight gain with antidepressants and lithium. J. Clin. Psychopharmacol. 8:1988;323-330
8. Hinze-Selch D., Schuld A., Kraus T., Kuhn M., Uhr M., Haack M., Pollmächer T. Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology. 23:2000;13-19
9. Kawachi I. Physical and psychological consequences of weight gain. J. Clin. Psychiatr. 60(Suppl 21):1999;5-9
10. Kazes M., Danion J.M., Grange D., Pradignac A., Simon C., Burrus-Mehl F., Schlienger J.L., Singer L. Eating behaviour and depression before and after antidepressant treatment: a prospective, naturalistic study. J. Affect. Disord. 30:1994;193-207
11. Kraus T., Haack M., Schuld A., Hinze-Selch D., Kühn M., Uhr M., Pollmächer T. Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am. J. Psychiatr. 156:1999;312-314
12. Kraus T., Haack M., Schuld A., Hinze-Selch D., Koethe D., Pollmächer T. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry. 35:2002;220-225
13. Kutscher E.C., Lund B.C., Hartman B.A. Peripheral edema associated with mirtazapine. Ann. Pharmacother. 35:2001;1494-1495
14. Majeroni B.A., Hess A. The pharmacologic treatment of depression. J. Am. Board Family Pract. 11:1998;127-139
15. Paykel E.S., Mueller P.S., Del V. Amitriptyline, weight gain and carbohydrate craving: a side effect. Brit. J. Psychiatr. 123:1973;501-507
16. Pijl H., Meinders A.E. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Safety. 14:1996;329-342
17. Pollmächer T., Hinze-Selch D., Mullington J. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J. Clin. Psychopharmacol. 16:1996;403-409
18. Pollmächer T., Haack M., Schuld A., Kraus T., Hinze-Selch D. Effects of antipsychotic drugs on cytokine networks. J. Psychiatr. Res. 34:2000;369-382
19. Recasens C. Body weight changes and psychotropic drug treatment: neuroleptics. Encephale. 27:2001;269-276
20. Reif A., Pfuhlmann B. Venlafaxine and reversible blepharoedema. Int. J. Neuropsychopharmacol. 5:2002;413-414
21. Schuld A., Kraus T., Haack M., Hinze-Selch D., Kuhn M., Pollmächer T. Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophrenia Res. 102:2000;1-3
22. Stunkard A.J., Fernstrom M.H., Price A., Frank E., Kupfer D.J. Direction of weight change in recurrent depression. Consistency across episodes. Arch. Gen. Psychiatr. 47:1990;857-860
23. Vanina Y., Podolskaya A., Sedky K., Shahab H., Siddiqui A., Munshi F., Lippmann S. Body weight changes associated with psychopharmacology. Psychiatr. Serv. 53:2002;842-847
24. Zimmermann U., Kraus T., Himmerich H., Schuld A., Pollmächer T. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J. Psychiatr. Res. 37:2003;193-220